Literature DB >> 14159445

IATROGENIC ENDOMETRIAL PATTERNS.

D CHARLES.   

Abstract

The histological patterns exhibited in the endometrium due to the newer progestational agents cannot be correlated with the patient's menstrual cycle or the physiological endometrium which follows ovulation. The oral progestational agents which have been produced during the past few years have had wide clinical application. Although the 19-nor-steroids and the derivatives of 17 alphahydroxyprogesterone differ in chemical structure, they produce similar histological appearances in the endometrium. Prolonged use of these compounds produces atrophy of the endometrial glands and a cellular stroma which might be mistaken for endometrial sarcoma. In view of the fact that such compounds are widely used in clinical practice and as contraceptive agents, it is essential that the pathologist should be aware of the bizarre endometrial patterns which they may produce; the more important of these changes are illustrated and discussed.

Entities:  

Keywords:  CONTRACEPTIVES, ORAL; DIETHYLSTILBESTROL; DYSMENORRHEA; ENDOMETRIAL HYPERPLASIA; ENDOMETRIOSIS; HYDROXYPROGESTERONE; IATROGENIC DISEASE; NORETHINDRONE; NORETHYNODREL; PATHOLOGY; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1964        PMID: 14159445      PMCID: PMC480726          DOI: 10.1136/jcp.17.3.205

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Inherent estrogenicity of norethindrone and norethynodrel: comparison with other synthetic progestins and progesterone.

Authors:  C A PAULSEN; R B LEACH; J LANMAN; N GOLDSTON; W O MADDOCK; C G HELLER
Journal:  J Clin Endocrinol Metab       Date:  1962-10       Impact factor: 5.958

2.  Pseudomalignant endometrial changes induced by administration of new synthetic progestins.

Authors:  M B DOCKERTY; R A SMITH; R E SYMMONDS
Journal:  Proc Staff Meet Mayo Clin       Date:  1959-06-24

3.  Urinary OEstrogen Metabolites of 19-Norethisterone and its Esters [Summary].

Authors:  J B Brown; H A Blair
Journal:  Proc R Soc Med       Date:  1960-06
  3 in total
  5 in total

1.  Iatrogenic Endometrial Patterns.

Authors: 
Journal:  Can Med Assoc J       Date:  1964-09-26       Impact factor: 8.262

Review 2.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

3.  Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.

Authors:  B C Zook; I Spiro; R Hertz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

4.  Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapy.

Authors:  Deanna M Janzen; Miguel A Rosales; Daniel Y Paik; Daniel S Lee; Daniel A Smith; Owen N Witte; M Luisa Iruela-Arispe; Sanaz Memarzadeh
Journal:  Cancer Res       Date:  2013-06-06       Impact factor: 12.701

5.  Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.

Authors:  Amber A Bokhari; Tabari M Baker; Batsukh Dorjbal; Sana Waheed; Christopher M Zahn; Chad A Hamilton; G Larry Maxwell; Viqar Syed
Journal:  Oncotarget       Date:  2016-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.